Skip to content
2000
Volume 33, Issue 4
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Introduction

This study aimed to develop, characterize, optimize, and evaluate the drug and stability of miconazole nitrate (MN)-loaded nanocrystal for topical drug delivery. MN is an antifungal agent with poor oral bioavailability and significant first-pass metabolism, necessitating alternative administration routes. Nanoformulations with lipidic/polymeric nanoparticles can overcome conventional system formulation limitations. However, it resulted in controlled MN drug release for up to 48 h and greater skin flux than did a 1% MN solution. This study aimed to identify optimized, stable, and effective MN-loaded nanocrystal-based hydrogels for topical drug delivery.

Methods

The nanocrystals (PN1-PN12) were developed the precipitation method using Pluronic F-127 as a nonionic copolymer surfactant and stabilizer. The compatibility was evaluated differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier transform infrared spectroscopy (FT-IR). With the help of the zetasizer, particle size, PDI, and Zeta Potential are determined. The drug release was determined using the dialysis bag method. Carbopol 934-P and methylparaben were dissolved in distilled water with heat and constant stirring to prevent agglomeration. Permeation experiments used excised abdominal skin from Wistar rats euthanized by cervical dislocation.

Results

The highest solubility was found in PF-127, followed by Pluronic F68. Nanocrystals were prepared the antisolvent precipitation method. The new diffraction pattern of the nanocrystals confirms their crystalline nature and complexation with the polymer, supporting the DSC and FT-IR findings. The developed nanocrystal shows a subtle shift from 1587 to 1589 cm-1, with no significant changes in the vibrational frequencies of the physical mixture. The PN5 formulation, with a small PS of 303.4 nm, a low PDI of 0.248, the highest drug content of 99.23 ± 5.23%, and a % cumulative drug release of 92.32 ± 3.27, was selected for further characterization. The PN5 formulations were stored under various conditions for 3 months, resulting in consistent particle sizes. SEM images revealed long, crystalline MN structures and needle-like nanocrystals. PN5 was optimized for developing a topical nanocrystal gel (PG1), which provided sustained drug release and retained significantly more drug than the other formulations did. PG1 remained stable during the 3-month storage.

Conclusion

The PN5 formulation, optimized for developing a topical nanocrystal gel, resulted in consistent particle size, sustained drug release, and stability over 3 months.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673339390250605054706
2025-07-28
2026-02-24
Loading full text...

Full text loading...

References

  1. YeoI.J. YunJ. SonD.J. HanS.B. HongJ.T. Antifungal drug miconazole ameliorated memory deficits in a mouse model of LPS-induced memory loss through targeting iNOS.Cell Death Dis.202011862310.1038/s41419‑020‑2619‑532796824
    [Google Scholar]
  2. TejadaG. BarreraM.G. GarcíaP. SortinoM. LamasM.C. LassalleV. AlvarezV. LeonardiD. Nanoparticulated systems based on natural polymers loaded with miconazole nitrate and lidocaine for the treatment of topical candidiasis.AAPS PharmSciTech202021727810.1208/s12249‑020‑01826‑633033939
    [Google Scholar]
  3. Al-MaghrabiP.M. KhafagyE.S. GhorabM.M. GadS. Influence of formulation variables on miconazole nitrate–loaded lipid based nanocarrier for topical delivery.Colloids Surf. B Biointerfaces202019311104610.1016/j.colsurfb.2020.11104632416518
    [Google Scholar]
  4. SinghS. PatilV.M. PaliwalS.K. MasandN. Nanotechnology-based drug delivery of topical antifungal agents.Pharm. Nanotechnol.20231110.2174/221173851166623081812503137594096
    [Google Scholar]
  5. RasoolM. MazharD. AfzalI. ZebA. KhanS. AliH. In vitro and in vivo characterization of miconazole nitrate loaded transethosomes for the treatment of cutaneous candidiasis.Int. J. Pharm.202364712356310.1016/j.ijpharm.2023.12356337907141
    [Google Scholar]
  6. PhechkrajangC. PhiphitphibunsukW. SukthongchaikoolR. NuchtavornN. LeanpolchareanchaiJ. Development of miconazole-loaded microemulsions for enhanced topical delivery and non-destructive analysis by near-infrared spectroscopy.Pharmaceutics2023156163710.3390/pharmaceutics1506163737376085
    [Google Scholar]
  7. AmbreenZ. FaranS.A. DanielA. KhalidS.H. KhanI.U. AsifM. RehmanA. MehmoodH.Q. AsgharS. Physicochemical, rheological and antifungal evaluation of miconazole nitrate organogels for topical delivery.Pak. J. Pharm. Sci.2022354(Special)1215122110.36721/PJPS.2022.35.4.SP.1215‑1221.136218100
    [Google Scholar]
  8. FarooqU. RasulA. ZafarullahM. AbbasG. RasoolM. AliF. AhmedS. JavaidZ. AbidZ. RiazH. Mahmood ArshadR.K. MaryamS. AmnaN. AsifK. Nanoemulsions as novel nanocarrieres for drug delivery across the skin: In vitro, in vivo evaluation of miconazole nanoemulsions for treatment of Candidiasis albicans.Des. Monomers Polym.202124124025810.1080/15685551.2021.196572434434070
    [Google Scholar]
  9. BhalekarM.R. PokharkarV. MadgulkarA. PatilN. PatilN. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery.AAPS PharmSciTech200910128929610.1208/s12249‑009‑9199‑019294517
    [Google Scholar]
  10. AsgharZ. JamshaidT. Sajid-ur-RehmanM. JamshaidU. GadH.A. Novel transethosomal gel containing miconazole nitrate; Development, characterization, and enhanced antifungal activity.Pharmaceutics20231511253710.3390/pharmaceutics1511253738004517
    [Google Scholar]
  11. FarooqU. RasulA. SherM. QadirM.I. NazirI. MehmoodY. RiazH. ShahP.A. JamilQ.A. KhanB.A. Development, characterization and evaluation of anti- fungal activity of miconazole based nanogel prepared from biodegradable polymer.Pak. J. Pharm. Sci.2020331(Special)44945732173643
    [Google Scholar]
  12. Abdel-RashidR.S. HelalD.A. Alaa-EldinA.A. Abdel- MonemR. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: In vitro and ex vivo evaluation.Drug Deliv.202229129430410.1080/10717544.2022.202653535037528
    [Google Scholar]
  13. BaveloniF.G. RiccioB.V.F. Di FilippoL.D. FernandesM.A. MeneguinA.B. ChorilliM. Nanotechnology-based drug delivery systems as potential for skin application: A review.Curr. Med. Chem.202128163216324810.2174/092986732766620083112565632867631
    [Google Scholar]
  14. SunL. XiangH. GeC. ChenX. ZhangQ. ZhangY. MiaoX. A nanocrystals-based topical drug delivery system with improved dermal penetration and enhanced treatment of skin diseases.J. Biomed. Nanotechnol.202117122319233710.1166/jbn.2021.320234974856
    [Google Scholar]
  15. LiuY. ZhaoJ. ChenJ. MiaoX. Nanocrystals in cosmetics and cosmeceuticals by topical delivery.Colloids Surf. B Biointerfaces202322711338510.1016/j.colsurfb.2023.11338537270904
    [Google Scholar]
  16. RahmanM. SinghJ.G. AfzalO. AltamimiA.S.A. AlrobaianM. HaneefJ. BarkatM.A. AlmalkiW.H. HandaM. ShuklaR. Nasar Mir Najib UllahS. KumarV. BegS. Preparation, characterization, and evaluation of curcumin–graphene oxide complex-loaded liposomes against Staphylococcus aureus in topical disease.ACS Omega2022748434994350910.1021/acsomega.2c0394036506117
    [Google Scholar]
  17. SinhaB. MüllerR.H. MöschwitzerJ.P. Systematic investigation of the cavi-precipitation process for the production of ibuprofen nanocrystals.Int. J. Pharm.2013458231532310.1016/j.ijpharm.2013.10.02524148667
    [Google Scholar]
  18. ChangD. MaY. CaoG. WangJ. ZhangX. FengJ. WangW. Improved oral bioavailability for lutein by nanocrystal technology: Formulation development, in vitro and in vivo evaluation.Artif. Cells Nanomed. Biotechnol.20184651018102410.1080/21691401.2017.135873228749189
    [Google Scholar]
  19. ChaudharyS. GargT. RathG. MurthyR.R. GoyalA.K. Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis.Artif. Cells Nanomed. Biotechnol.20154431610.3109/21691401.2014.100049325783855
    [Google Scholar]
  20. MohamedA.R. AbolmagdE. BadrawyM. NourI.M. Innovative earth-friendly uv-spectrophotometric technique for in vitro dissolution testing of miconazole nitrate and nystatin in their vaginal suppositories: Greenness assessment.J. AOAC Int.202210561528153510.1093/jaoacint/qsac07435699478
    [Google Scholar]
  21. HussainA. BegumA. RahmanA. Effects of annealing on nanocrystalline Bi2S3 thin films prepared by chemical bath deposition.Mater. Sci. Semicond. Process.2014211748110.1016/j.mssp.2014.01.029
    [Google Scholar]
  22. JurcaT. JózsaL. SuciuR. PallagA. MarianE. BácskayI. MureșanM. StanR.L. CeveiM. CioarăF. VicașL. FehérP. Formulation of topical dosage forms containing synthetic and natural anti-inflammatory agents for the treatment of rheumatoid arthritis.Molecules20202612410.3390/molecules2601002433374575
    [Google Scholar]
  23. PreetS. KaurJ. RazaK. Nisin loaded carbopol gel against Pseudomonas aeruginosa infected third-degree burns: A therapeutic intervention.Wound Repair Regen.202129571172410.1111/wrr.1290933721379
    [Google Scholar]
  24. ScomoroscencoC. TeodorescuM. RaducanA. StanM. VoicuS.N. TricaB. NinciuleanuC.M. NistorC.L. MihaescuC.I. PetcuC. CintezaL.O. Novel gel microemulsion as topical drug delivery system for curcumin in dermatocosmetics.Pharmaceutics202113450510.3390/pharmaceutics1304050533916981
    [Google Scholar]
  25. PawarV.K. GuptaS. SinghY. MeherJ.G. SharmaK. SinghP. GuptaA. BoraH.K. ChaurasiaM. ChourasiaM.K. Pluronic F-127 stabilised docetaxel nanocrystals improve apoptosis by mitochondrial depolarization in breast cancer cells: Pharmacokinetics and toxicity assessment.J. Biomed. Nanotechnol.201511101747176310.1166/jbn.2015.215826502638
    [Google Scholar]
  26. JainS. ReddyV.A. AroraS. PatelK. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.Drug Deliv. Transl. Res.20166549851010.1007/s13346‑016‑0297‑827129488
    [Google Scholar]
  27. ZongR. RuanH. ZhuW. ZhangP. FengZ. LiuC. FanS. LiangH. LiJ. Curcumin nanocrystals with tunable surface zeta potential: Preparation, characterization and antibacterial study.J. Drug Deliv. Sci. Technol.20227610377110.1016/j.jddst.2022.103771
    [Google Scholar]
  28. RojekB. GazdaM. PlenisA. FTIR, Raman spectroscopy and HT-XRD in compatibility study between naproxen and excipients.Spectrochim. Acta A Mol. Biomol. Spectrosc.202330212304810.1016/j.saa.2023.12304837354860
    [Google Scholar]
  29. RossettiA. RealD.A. BarrientosB.A. AllemandiD.A. ParedesA.J. RealJ.P. PalmaS.D. Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin/Tween 80® nanocrystals formulated through wet milling and freeze-drying.Int. J. Pharm.2024650123720, 650, 12372010.1016/j.ijpharm.2023.12372038110014
    [Google Scholar]
  30. MelianM.E. ParedesA. MunguíaB. ColobbioM. RamosJ.C. TeixeiraR. MantaE. PalmaS. FaccioR. DomínguezL. Nanocrystals of novel valerolactam-fenbendazole hybrid with improved in vitro dissolution performance.AAPS PharmSciTech202021723710.1208/s12249‑020‑01777‑y32808055
    [Google Scholar]
  31. WadhawanJ. ParmarP.K. BansalA.K. Nanocrystals for improved topical delivery of medium soluble drug: A case study of acyclovir.J. Drug Deliv. Sci. Technol.20216510266210.1016/j.jddst.2021.102662
    [Google Scholar]
  32. Le GarsM. RogerP. BelgacemN. BrasJ. Role of solvent exchange in dispersion of cellulose nanocrystals and their esterification using fatty acids as solvents.Cellulose20202784319433610.1007/s10570‑020‑03101‑0
    [Google Scholar]
  33. JahangirM.A. ImamS.S. MuheemA. ChettupalliA. Al-AbbasiF.A. NadeemM.S. KazmiI. AfzalM. AlshehriS. Nanocrystals: Characterization overview, applications in drug delivery, and their toxicity concerns.J. Pharm Innov.202217237248
    [Google Scholar]
  34. PelikhO. StahrP.L. HuangJ. GerstM. ScholzP. DietrichH. GeiselN. KeckC.M. Nanocrystals for improved dermal drug delivery.Eur. J. Pharm. Biopharm.201812817017810.1016/j.ejpb.2018.04.02029680482
    [Google Scholar]
  35. Mol PereiraE.A. SantosC.S. Biosurfactants as stabilizers of niclosamide nanocrystals: Enhancing stability, solubility, and cytotoxicity profiling.J. Drug Deliv. Sci. Technol.202410010609510.1016/j.jddst.2024.106095
    [Google Scholar]
  36. ChenC. YuG. ZhouY. FuH. HuangW. WangZ. LuoX. YinX. MaoS. ZhuK. Enhanced stability and dissolution of curcumin nanocrystals stabilized by octenyl succinic anhydride modified starch.J. Drug Deliv. Sci. Technol.20249610570110.1016/j.jddst.2024.105701
    [Google Scholar]
  37. CastañedaL. A facile method for formulation of atenolol nanocrystal drug with enhanced bioavailability.Nanocrystalline Materials.Intech Open201911410.5772/intechopen.88191
    [Google Scholar]
  38. MazumderR. PaulS.D. Formulation and evaluation of atenolol nanocrystals using 3(2) full factorial design.Nanosc. Nanotechnol. Asia.2020103306315
    [Google Scholar]
  39. KumarA. ValamlaB. ThakorP. CharyP.S. RajanaN. MehraN.K. Development and evaluation of nanocrystals loaded hydrogel for topical application.J. Drug Deliv. Sci. Technol.20227410350310.1016/j.jddst.2022.103503
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673339390250605054706
Loading
/content/journals/cmc/10.2174/0109298673339390250605054706
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test